BDBM237330 US10052306, 176::rac-4-(2-((3aR,5r,6aS)-5- benzyl-5- methoxyhexahydrocyclo- penta[c]pyrrol-2(1H)-yl)- 1-hydroxyethyl)phenol

SMILES CO[C@]1(Cc2ccccc2)C[C@@H]2CN(CC(O)c3ccc(O)cc3)C[C@@H]2C1

InChI Key InChIKey=RESXGNDYRBSEMJ-WVTBVLOCSA-N

Data  1 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 237330   

TargetGlutamate receptor ionotropic, NMDA 2B(Homo sapiens (Human))
Cadent Therapeutics

US Patent
LigandPNGBDBM237330(US10052306, 176 | rac-4-(2-((3aR,5r,6aS)-5- benzyl...)
Affinity DataIC50:  32.4nMAssay Description:To each well of the plate, 10 μL test compound, control (MK801) or HHnoCa buffer was added to a final concentration of 10 μM with a final c...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent